VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)

1,166 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q4 2021.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 1,015 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 229,577,277 shares of 256,606,920 outstanding shares and own 89.47% of the company stock.
Largest 10 shareholders include BlackRock Inc. (23,944,931 shares), VANGUARD GROUP INC (20,155,842 shares), STATE STREET CORP (12,356,915 shares), Capital World Investors (11,520,855 shares), ALLIANCEBERNSTEIN L.P. (10,443,771 shares), FMR LLC (9,093,853 shares), LOOMIS SAYLES & CO L P (6,635,253 shares), WELLINGTON MANAGEMENT GROUP LLP (6,518,455 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,421,291 shares), and Clearbridge Investments, LLC (5,196,730 shares).
This table shows the top 1015 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.